First genetically-engineered malaria vaccine to enter human trials
Date: 30.7.2009
Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in collaboration with researchers from the US, Japan and Canada, will be trialled in humans from early next year.
Source "Physorg":[ http://www.physorg.com/news168020667.html]
